NO156689C - Fremgangsmaate for fremstilling av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on. - Google Patents

Fremgangsmaate for fremstilling av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on.

Info

Publication number
NO156689C
NO156689C NO810639A NO810639A NO156689C NO 156689 C NO156689 C NO 156689C NO 810639 A NO810639 A NO 810639A NO 810639 A NO810639 A NO 810639A NO 156689 C NO156689 C NO 156689C
Authority
NO
Norway
Prior art keywords
carbamyl
bipyridine
cyano
procedure
preparation
Prior art date
Application number
NO810639A
Other languages
English (en)
Other versions
NO810639L (no
NO156689B (no
Inventor
Karl Olaf Gelotte
Chester Joseph Opalka Jr
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO810639L publication Critical patent/NO810639L/no
Publication of NO156689B publication Critical patent/NO156689B/no
Publication of NO156689C publication Critical patent/NO156689C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO810639A 1980-02-26 1981-02-25 Fremgangsmaate for fremstilling av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on. NO156689C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (3)

Publication Number Publication Date
NO810639L NO810639L (no) 1981-08-27
NO156689B NO156689B (no) 1987-07-27
NO156689C true NO156689C (no) 1987-11-04

Family

ID=22416880

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810639A NO156689C (no) 1980-02-26 1981-02-25 Fremgangsmaate for fremstilling av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on.

Country Status (28)

Country Link
US (1) US4264609A (no)
JP (1) JPS56128758A (no)
KR (2) KR840002067B1 (no)
AR (1) AR230630A1 (no)
AT (2) AT380237B (no)
AU (1) AU541644B2 (no)
BE (1) BE887663A (no)
CA (1) CA1128523A (no)
CH (1) CH647509A5 (no)
DE (1) DE3107306A1 (no)
DK (1) DK171253B1 (no)
ES (1) ES499776A1 (no)
FI (1) FI76787C (no)
FR (1) FR2476646A1 (no)
GB (1) GB2070600B (no)
HK (1) HK71789A (no)
IE (1) IE51696B1 (no)
IL (1) IL62161A (no)
IT (1) IT1210992B (no)
LU (1) LU83169A1 (no)
MX (1) MX6908E (no)
NL (1) NL192109C (no)
NO (1) NO156689C (no)
NZ (1) NZ196282A (no)
PH (2) PH19904A (no)
PT (1) PT72573B (no)
SE (2) SE437514B (no)
ZA (1) ZA811124B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77817T1 (de) 1985-04-30 1992-07-15 Dresden Arzneimittel 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
NO810639L (no) 1981-08-27
ATA88581A (de) 1985-09-15
SE8402727L (sv) 1984-05-21
FI76787C (fi) 1988-12-12
MX6908E (es) 1986-11-07
IT1210992B (it) 1989-09-29
IT8119952A0 (it) 1981-02-24
AT380236B (de) 1986-04-25
CA1128523A (en) 1982-07-27
FI76787B (fi) 1988-08-31
PT72573B (en) 1982-02-12
DK83981A (da) 1981-08-27
SE8101205L (sv) 1981-08-27
PT72573A (pt) 1981-03-01
NL8100922A (nl) 1981-09-16
CH647509A5 (fr) 1985-01-31
FI810582L (fi) 1981-08-27
DK171253B1 (da) 1996-08-12
NL192109B (nl) 1996-10-01
US4264609A (en) 1981-04-28
IL62161A (en) 1984-06-29
FR2476646B1 (no) 1984-08-17
SE452764B (sv) 1987-12-14
DE3107306A1 (de) 1981-12-17
FR2476646A1 (fr) 1981-08-28
IL62161A0 (en) 1981-03-31
PH17145A (en) 1984-06-04
IE810397L (en) 1981-08-26
JPH0141626B2 (no) 1989-09-06
DE3107306C2 (no) 1990-11-29
IE51696B1 (en) 1987-02-18
ZA811124B (en) 1982-03-31
NL192109C (nl) 1997-02-04
AU541644B2 (en) 1985-01-17
SE8402727D0 (sv) 1984-05-21
HK71789A (en) 1989-09-14
LU83169A1 (fr) 1981-09-11
JPS56128758A (en) 1981-10-08
AR230630A1 (es) 1984-05-31
NZ196282A (en) 1983-12-16
ATA305683A (de) 1985-09-15
PH19904A (en) 1986-08-13
GB2070600A (en) 1981-09-09
AU6748781A (en) 1981-09-03
GB2070600B (en) 1984-07-11
BE887663A (fr) 1981-08-25
NO156689B (no) 1987-07-27
AT380237B (de) 1986-04-25
KR840002066B1 (ko) 1984-11-09
KR830005143A (ko) 1983-08-03
SE437514B (sv) 1985-03-04
ES499776A1 (es) 1984-06-16
KR840002067B1 (ko) 1984-11-09

Similar Documents

Publication Publication Date Title
NO803851L (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO852124L (no) Fremgangsmaate ved fremstilling av kinolonderivater.
NO821586L (no) Fremgangsmaate til fremstilling av 1,2-diamino-cyklobuten-3,4-dioner.
NO874764L (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
FI850163L (fi) Gjutfoerfarande och form foer laogtrycksgjutning under anvaendning av en foergasbar modell och sandform framstaelld utan bindemedel.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
FI891407A (fi) Anordning foer svaellning av naeringsaemnen, njutningsmedel och liknande.
DK372380A (da) Fremgangsmaade til fremstilling af 5,6,7-trinor4,8-inter-m-phemylen pgi2 derivater
NO155051C (no) Fremgangsmaate for fremstilling av alfa-klorerte klorformiaer.
FI852765A0 (fi) Foerfarande foer framstaellning av saosom hjaertmedicin anvaendbara 1,6-naftyridin 2(1h)-oner.
NO158948C (no) Fremgangsmaate for fremstilling av enzymet kolesterase.
DK158353C (da) Analogifremgangsmaade til fremstilling af 3, 6, 7, 8-substituerede s-triazoloe4,3-baapyridaziner.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO154547C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO824194L (no) Fartoey av typen med variabel luftpute.
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO811751L (no) Fremgangsmaate for fremstilling av 3-pikolin.
NO156689C (no) Fremgangsmaate for fremstilling av 5-(cyano eller karbamyl)-(3,4-bipyridin)-6(1h)-on.
NO810114L (no) Fremgangsmaate for fremstilling av kijanimicin.
ES513384A0 (es) "metodo para la fabricacion de derivados de la quinolina".
NO155666C (no) Fremgangsmaate for fremstilling av 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
SE8101204L (sv) Forfarande for framstellning av 5-cyano-(3,4'-bipyridin)-6(1h)-on